201 related articles for article (PubMed ID: 32537088)
41. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
42. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome.
Demuth I; Digweed M
Oncogene; 2007 Dec; 26(56):7792-8. PubMed ID: 18066092
[TBL] [Abstract][Full Text] [Related]
43. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.
Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J
Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123
[TBL] [Abstract][Full Text] [Related]
44. 657del5 mutation of the Nijmegen breakage syndrome gene (NBS1) in the Turkish population.
Tekin M; Akcayoz D; Ucar C; Gulen H; Akar N
Hum Biol; 2005 Jun; 77(3):393-7. PubMed ID: 16392640
[TBL] [Abstract][Full Text] [Related]
45. Nijmegen breakage syndrome detected by newborn screening for T cell receptor excision circles (TRECs).
Patel JP; Puck JM; Srinivasan R; Brown C; Sunderam U; Kundu K; Brenner SE; Gatti RA; Church JA
J Clin Immunol; 2015 Feb; 35(2):227-33. PubMed ID: 25677497
[TBL] [Abstract][Full Text] [Related]
46. Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application.
Salewsky B; Hildebrand G; Rothe S; Parplys AC; Radszewski J; Kieslich M; Wessendorf P; Krenzlin H; Borgmann K; Nussenzweig A; Sperling K; Digweed M
Mol Ther; 2016 Feb; 24(1):117-24. PubMed ID: 26265251
[TBL] [Abstract][Full Text] [Related]
47. Clinical presentation and mutation identification in the NBS1 gene in a boy with Nijmegen breakage syndrome.
Kleier S; Herrmann M; Wittwer B; Varon R; Reis A; Horst J
Clin Genet; 2000 May; 57(5):384-7. PubMed ID: 10852373
[TBL] [Abstract][Full Text] [Related]
48. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
49. 657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls.
Resnick IB; Kondratenko I; Pashanov E; Maschan AA; Karachunsky A; Togoev O; Timakov A; Polyakov A; Tverskaya S; Evgrafov O; Roumiantsev AG
Am J Med Genet A; 2003 Jul; 120A(2):174-9. PubMed ID: 12833396
[TBL] [Abstract][Full Text] [Related]
50. Speech impairment in Nijmegen breakage syndrome: a rare anomaly.
Gupta D; Nagarkar A
Int J Pediatr Otorhinolaryngol; 2009 Jun; 73(6):873-5. PubMed ID: 19195720
[TBL] [Abstract][Full Text] [Related]
51. T-lymphoblastic leukemia/lymphoma in macedonian patients with Nijmegen breakage syndrome.
Kocheva SA; Martinova K; Antevska-Trajkova Z; Coneska-Jovanova B; Eftimov A; Dimovski AJ
Balkan J Med Genet; 2016 Jul; 19(1):91-94. PubMed ID: 27785413
[TBL] [Abstract][Full Text] [Related]
52. NBS1, the Nijmegen breakage syndrome gene product, regulates neuronal proliferation and differentiation.
Lee WT; Chang WH; Huang CH; Wu KJ
J Neurochem; 2007 Jul; 102(1):141-52. PubMed ID: 17442057
[TBL] [Abstract][Full Text] [Related]
53. Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence.
Meijers RWJ; Dzierzanowska-Fangrat K; Zborowska M; Solarska I; Tielemans D; van Turnhout BAC; Driessen G; van der Burg M; van Dongen JJM; Chrzanowska KH; Langerak AW
J Clin Immunol; 2017 Feb; 37(2):133-142. PubMed ID: 28000062
[TBL] [Abstract][Full Text] [Related]
54. DNA repair functional analyses of NBN hypomorphic variants associated with NBN-related infertility.
Fiévet A; Bellanger D; Zahed L; Burglen L; Derrien AC; Dubois d'Enghien C; Lespinasse J; Parfait B; Pedespan JM; Rieunier G; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2020 Mar; 41(3):608-618. PubMed ID: 31729086
[TBL] [Abstract][Full Text] [Related]
55. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
56. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M
PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167
[TBL] [Abstract][Full Text] [Related]
57. [Ocular findings in Nijmegen breakage syndrome].
Grałek M; Chrzanowska KH; Kanigowska K; Kocyła-Karczmarewicz B
Klin Oczna; 2011; 113(4-6):153-5. PubMed ID: 21913446
[TBL] [Abstract][Full Text] [Related]
58. Nijmegen Breakage Syndrome fibroblasts and iPSCs: cellular models for uncovering disease-associated signaling pathways and establishing a screening platform for anti-oxidants.
Mlody B; Wruck W; Martins S; Sperling K; Adjaye J
Sci Rep; 2017 Aug; 7(1):7516. PubMed ID: 28790359
[TBL] [Abstract][Full Text] [Related]
59. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
[TBL] [Abstract][Full Text] [Related]
60. The NBS1-ATM connection revisited.
Difilippantonio S; Nussenzweig A
Cell Cycle; 2007 Oct; 6(19):2366-70. PubMed ID: 17881893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
